Group 1 - The brain-computer interface (BCI) sector is experiencing active performance, with companies like Aipeng Medical and Innovation Medical seeing significant stock increases, indicating a potential explosive growth phase for the industry [1] - A research team led by Professor Jin Jing from East China University of Science and Technology has developed a new mixed-reality enhanced BCI system for quadruped control, which integrates mixed reality technology with BCI for efficient and stable control of robotic dogs [1][2] - The traditional BCI systems face challenges in real-world applications, such as environmental light interference and poor portability, which limit their performance and application range. The new framework proposed by Jin's team aims to enhance BCI systems with features like anti-interference, high performance, and portability [1] Group 2 - The rapid development of BCI technology is supported by advancements in artificial intelligence, neuroscience, and sensors, with China's "14th Five-Year Plan" designating "brain science and brain-like research" as a key frontier technology project [2] - The global market for BCI technology is projected to reach $1.98 billion in 2023 and exceed $6 billion by 2028, with a compound annual growth rate of 25.22% over five years [2] - China is making significant strides in non-invasive BCI technology, with policies supporting the industry and a goal to achieve core technology autonomy and clinical application by 2030 [2][3] Group 3 - The BCI industry is witnessing breakthroughs in applications such as motor recovery, language communication, and hearing restoration, driven by technological advancements and supportive national policies [3] - Recent policy initiatives, including the National Medical Insurance Administration's decision to separately list new BCI technology pricing, are paving the way for clinical application and service charge pathways [3] - Domestic BCI companies are expected to gradually achieve commercialization due to technological innovations and policy incentives [3]

证券代码：300753 证券简称：爱朋医疗 江苏爱朋医疗科技股份有限公司 投资者关系活动记录表 编号：2025-002 | | 特定对象调研 分析师会议 | | --- | --- | | 投资者关系活动 | 媒体采访 业绩说明会 | | 类别 | 新闻发布会 路演活动 | | | 现场参观 | | | 其他（电话会议） | | | 中信建投证券吴严，中信建投证券徐超，华西证券赵晓燕，天风资管 许磊涛，上海烜鼎私募基金谭鹏，上海弈术投资孙宏廷，上海惠璞投 | | 参与单位名称及 | 资徐克，汇鸿汇升投资赵晓宇，理石投资宋雅晴，海南无量私募基金 | | 人员姓名 | 何晶，重庆钧山投资敖焱杰，中财招商投资集团朱凌云，上海久有私 | | | 募基金丁剑锋，上海智晶私募基金薛伟杰，上海国鸣投资张同鑫，上 | | | 海默驰投资刘猛，上海前点投资袁佳，浙江弘悦私募基金聂磊等 25 人 | | 时间 | 2025 年 2 月 19 日 15:00-17:00 | | 地点 | 爱朋医疗上海会议室现场 | | 上市公司接待人 员姓名 | 董事会秘书叶俞飞先生，证券事务代表黄秀秀女士 | 投资者关系活动主要 ...

投资者关系活动主要内容介绍 证券代码：300753 证券简称：爱朋医疗 江苏爱朋医疗科技股份有限公司 投资者关系活动记录表 编号：2025-001 | | 特定对象调研 分析师会议 | | | --- | --- | --- | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | 类别 | 新闻发布会 路演活动 | | | | 现场参观 | | | | 其他（电话会议） | | | | 中信建投王在存，中信建投刘慧彬，中信建投华冉，国泰基金邱晓旭， 国泰基金王彧，源乐晟基金欧阳明，源乐晟基金吴海燕，源乐晟基金 | | | 参与单位名称及 | 王可蓥，人保养老基金于秋萍，人保养老基金毛雅婷；天风证券周海 | | | 人员姓名 | 涛，湘财证券蒋栋，永赢基金张蕊，永赢基金单林，国联安基金赵子 | | | | 淇，深积资产杨森，德邦基金揭诗琪，浦银安盛基金张瑞，鹤禧投资 | | | | 吴迪龙等 19 人 | | | 时间 | 10:00-17:00 | | | | 2025 年 1 月 3 日 | | | 地点 | 网络电话会议；爱朋医疗上海会议室现场 | | | 上市公司接待人 | 董事长 ...

Government and Industry Collaboration - Encourage collaboration between national laboratories, research institutions, and medical institutions in Shanghai to achieve leading and disruptive theoretical results [1] Medical AI Development Plan - Shanghai Municipal Government issued the "Shanghai Medical Artificial Intelligence Work Plan (2025-2027)" on December 24, focusing on advancing research in AI cognitive intelligence and reinforcement learning [2] - Support innovative exploration in frontier medical fields such as brain science, brain-computer interfaces, and computational biology [2] Market Performance - Brain engineering concept stocks strengthened, with Aipeng Medical rising over 6%, Fudan Forward rising 5%, and Weisi Medical rising nearly 4% [2]

江苏爱朋医疗科技股份有限公司 关于控股股东、实际控制人协议转让公司部分股份 完成过户登记的公告 证券代码：300753 证券简称：爱朋医疗 公告编号：2024-048 本次协议转让股份过户登记前后，各方股份变动情况如下： 注：1、本公告中，占总股本比例数值按四舍五入精确到小数点后两位。若出现各分项数值之和与 总数尾数不符的情况，均为四舍五入原因造成。 2、以上有限售条件股份为高管锁定股。 公司控股股东、实际控制人王凝宇先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 江苏爱朋医疗科技股份有限公司（以下简称"公司"）于近日收到控股股东、实际控 制人王凝宇先生以及北京章泓私募基金管理有限公司（代表"章泓精选 1 号私募证券投资 基金"）（以下简称"章泓基金"）的通知，王凝宇先生通过协议转让方式向章泓基金转 让其持有的 7,058,000 股公司无限售流通股事项已完成证券过户登记手续。现将具体情况公 告如下： 一、本次协议转让的基本情况 王凝宇先生与章泓基金于 2024 年 9 月 29 日签署了《关于江苏爱朋 ...

证券代码：300753 证券简称：爱朋医疗 公告编号：2024-047 江苏爱朋医疗科技股份有限公司 关于理财产品到期赎回及继续使用闲置资金 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 江苏爱朋医疗科技股份有限公司（以下简称"公司"）于2023年10月20日召开第三届 董事会第六次会议、第三届监事会第六次会议，2023年11月7日召开了2023年第一次临 时股东大会，审议通过了《关于使用部分闲置募集资金及闲置自有资金进行现金管理的 议案》，同意公司在确保不影响正常运营和资金安全的前提下，使用闲置募集资金不超 过人民币1.2亿元（含本数）和闲置自有资金不超过人民币1亿元（含本数）进行现金管 理，用于购买期限在12个月以内（含）的安全性高、流动性好的理财产品，上述资金额 度自股东大会审议通过之日起24个月内可以滚动使用。股东大会授权董事长在额度范围 内行使该项投资决策权并签署相关合同文件，公司财务部门组织实施。具体内容详见公 司 于 2023 年 10 月 21 日 在 中 国 证 券 监 督 管 理 委 员 会 指 定 披 露 媒 体 巨 潮 资 讯 网 （w ...

证券代码：300753 证券简称：爱朋医疗 公告编号：2024-046 注：上表中如出现合计数与各分项数值总和不符，均为四舍五入原因造成。 2、股东股份累计质押情况 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： | | | | | | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股比 | 本次质押前 | 本次质押后 | 占其所 | 占公司 | 情况 | | 情况 | | | 名称 | （股） | 例 | 质押股份数 | 质押股份数 | 持股份 | 总股本 | 已质押股份 | 占已质 | 未质押股份 | 占未质 | | | | | 量（股） | 量（股） | 比例 | 比例 | 限售和冻结 | 押股份 | 限售和冻结 | 押股份 | | | | | | | | | 数量（股） | 比例 | 数量（股） | 比例 | 江苏爱朋医疗科技股份有限公司 关于控股股东、实际控制人部分股份解除质押的公告 本公司及董事会全体成员保证信息披露的 ...

董事会于近日收到公司董事会秘书缪飞先生提交的书面辞职报告。缪飞先生因个人 原因申请辞去公司董事会秘书职务，辞任后不再担任公司任何职务，其辞职报告自送达 公司董事会之日起生效。 证券代码：300753 证券简称：爱朋医疗 公告编号：2024-045 缪飞先生原定任期至 2025 年 8 月 5 日。截至本公告披露日，缪飞先生持有公司股 票 269,435 股，占公司总股本的 0.21%，其在任职期间不存在未履行承诺情况。辞任后， 缪飞先生将严格按照《深圳证券交易所上市公司自律监管指引第 18 号——股东及董事、 监事、高级管理人员减持股份》等相关法律、法规的规定进行股份管理。 缪飞先生在担任公司董事会秘书期间恪尽职守、勤勉尽责，公司董事会对缪飞先生 在任职期间为公司发展所做的贡献表示衷心感谢。 江苏爱朋医疗科技股份有限公司 关于变更董事会秘书及证券事务代表的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 江苏爱朋医疗科技股份有限公司（以下简称"公司"或"爱朋医疗"）于 2024 年 10 月 28 日召开了第三届董事会第九次会议，审议通过了《关于聘任董事会 ...

证券代码：300753 证券简称：爱朋医疗 公告编号：2024-044 江苏爱朋医疗科技股份有限公司 关于2024年前三季度计提资产减值准备及核销资产的公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 江苏爱朋医疗科技股份有限公司（以下简称"公司"）根据《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司 规范运作》《企业会计准则》等相关法律法规以及公司相关会计政策的规定，基于谨 慎性原则，为真实、准确、客观地反映公司的财务、资产和经营状况，对截止2024年9 月30日的合并报表范围内相关资产计提资产减值准备，对部分资产予以核销。现将具 体情况公告如下： 一、本次计提资产减值准备情况概述 （一）本次计提资产减值准备的原因 根据《企业会计准则》及公司会计政策的相关规定，为公允反映公司各类资产的 价值，公司对合并范围内截止2024年9月30日的各类资产进行了减值测试，对各类资产 的可变现性进行充分的评估和分析，认为上述资产中部分资产存在一定的减值迹象， 本着谨慎性原则，对可能发生资产减值损失的相关资产计提资产减值准 ...

Financial Performance - Revenue increased by 15% year-over-year, driven by strong sales in the North American market [1]. - Net profit margin improved to 12%, up from 10% in the previous quarter [2]. - Operating expenses rose by 8%, primarily due to increased marketing and R&D investments [3]. Market Expansion - The company successfully entered the European market, with initial sales exceeding expectations [4]. - A new distribution center was opened in Asia to support growing demand in the region [5]. - Strategic partnerships were formed with local retailers to enhance market penetration [6]. Product Development - Launched three new products in the tech segment, which have received positive customer feedback [7]. - R&D investment increased by 20% to accelerate innovation and product differentiation [8]. - The company plans to introduce a new line of eco-friendly products by the end of the year [9]. Operational Efficiency - Implemented a new supply chain management system, reducing delivery times by 15% [10]. - Automation initiatives in manufacturing led to a 10% reduction in production costs [11]. - Employee training programs were expanded to improve operational efficiency and reduce errors [12]. Sustainability Initiatives - Achieved a 25% reduction in carbon emissions through the adoption of renewable energy sources [13]. - Introduced a recycling program that has successfully diverted 30% of waste from landfills [14]. - The company committed to achieving net-zero emissions by 2030 [15]. Customer Engagement - Customer satisfaction scores improved by 5% due to enhanced after-sales support [16]. - Launched a loyalty program that has already attracted over 100,000 members [17]. - Social media engagement increased by 40%, driven by targeted marketing campaigns [18]. Risk Management - Identified potential supply chain disruptions and implemented contingency plans [19]. - Cybersecurity measures were strengthened to protect customer data and intellectual property [20]. - The company conducted a comprehensive risk assessment to mitigate financial and operational risks [21]. Corporate Governance - Appointed two new independent directors to the board, enhancing governance and oversight [22]. - Revised the company's code of conduct to align with global best practices [23]. - Conducted regular audits to ensure compliance with regulatory requirements [24]. Employee Development - Introduced a new leadership training program to develop future leaders within the organization [25]. - Employee retention rates improved by 8% due to enhanced benefits and career development opportunities [26]. - Launched a diversity and inclusion initiative to promote a more inclusive workplace [27]. Strategic Partnerships - Formed a joint venture with a leading technology firm to co-develop innovative solutions [28]. - Collaborated with a major logistics provider to optimize global distribution networks [29]. - Partnered with a non-profit organization to support community development projects [30].